1 withdrawn. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Withdrawn 1 |
Follow SCLC: new trials by email Literature Review of SCLC trials Research Report on SCLC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab MILs™ in Combination with Pembrolizumab - SCLC, NSCLC | Early Phase 1 | Withdrawn | Fox Chase Cancer Center | 2021-10-01 | 2021-10-08 |
pembrolizumab (1)